Answers are grounded in this paper and cite their sources.
IN 1958 a serendipitous observation led to the discovery that oral administration of small doses of neomycin reduced the concentration of plasma cholesterol in man.1 Neomycin is a nonabsorbable aminoglycoside antibiotic with a broad spectrum of activity. Since intramuscular administration of small absorbed amounts (<3 per cent of the oral dose) fails to alter cholesterol levels, the action of the drug appears to depend on its presence within the lumen of the gastrointestinal tract.2 My colleagues and I have studied the effects of 22 additional antibacterial drugs on plasma cholesterol levels in man; kanamycin, chlortetracycline, paromomycin, chloramphenicol and para-aminosalicylic acid . . .
No takes yet. Share an insight, caveat, or question.
Paul Samuel (1979) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: